Latest News & Features
Americas
A recent decision in Canada means defendants in patent infringement cases can raise the non-infringing alternative defence in response to damages claims. Mark Biernacki and Cameron Weir of Smart & Biggar/Fetherstonhaugh considers its potential impact on litigation between drugs companies. 20 August 2015
Americas
Sequenom has requested an en banc review of the US Court of Appeals for the Federal Circuit’s decision to invalidate one of its patents in its dispute with Ariosa Diagnostics, arguing that the decision creates an “existential threat” to patent protection. 19 August 2015
Americas
Pfizer’s $17 billion buyout of Hospira has been approved in Canada and Australia after the countries’ competition bureaus approved the deal. 18 August 2015
Americas
US hedge fund Ferrum Ferro Capital has asked a California court to reject Allergan’s complaint about malicious prosecution because it allegedly violates a state law designed to stop parties from intentionally burdening another party with a legal complaint. 17 August 2015
Americas
Law firm Dechert has hired Andrea Reid as partner to the firm’s intellectual property practice in Boston. 14 August 2015
Americas
Hedge fund manager Kyle Bass has fired a response to a motion filed by biotechnology company Celgene seeking to sanction him over “abusive” patent challenges, stating that profit motive is at the centre of every inter partes review filing. 13 August 2015
article
US Congress must exempt biopharmaceutical patents from PTAB review to ensure continued medical innovation, argues Peter Pitts of the Center for Medicine in the Public Interest. 13 August 2015
Big Pharma
The UK Intellectual Property Office has revealed the location for the country’s central and local divisions of the forthcoming Unified Patent Court. 12 August 2015
Americas
A US court has ruled that biotechnology company Regeneron engaged in “inequitable conduct” after finding that it withheld information from a patent application for a genetically modified mouse. 11 August 2015
Americas
Medical device makers Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, and Covidien will head back to a US court after the US Court of Appeals for the Federal Circuit revived their patent dispute concerning ultrasonic surgical devices. 10 August 2015